Woonsocket, Rhode Island — Omnicare, the country’s largest pharmacy provider to skilled nursing and assisted living facilities, took a significant step Wednesday in its ongoing bankruptcy, announcing a court-supervised sale process with a new potential buyer already lined up.
The company entered into an asset purchase agreement with GenieRx Holdings LLC, a joint venture between private investment firm Milrose Capital LLC and Integro Healthcare Services, which will serve as the so-called “stalking horse bidder” — essentially setting the floor price for what will become an open auction. Competing bids are due April 30, 2026, with an auction expected May 5 if multiple qualified offers come in.
For nursing home operators, the announcement is a reason to pay close attention. Omnicare handles prescription dispensing, clinical pharmacy programs, and medication management for thousands of long-term care facilities across the country. Any disruption to that supply chain — even a temporary one — carries real risk for residents who depend on daily medications.
Business As Usual — For Now
Company president David Azzolina said Omnicare intends to keep operating without interruption through the sale process. “GenieRx’s interest reflects the strength of Omnicare’s clinical expertise, the trust we have earned from the skilled nursing and senior living communities we serve, and the essential role our teams play in supporting high-quality care for residents,” he said in a statement.
According to the company, pharmacy services to skilled nursing facilities will continue, with ongoing clinical programs tied to CMS value-based purchasing measures, pricing transparency initiatives, and analytics tools supporting accountable care organizations and special needs plans.
But “business as usual” in the middle of a bankruptcy auction is easier said than done. Nursing home administrators who rely on Omnicare for dispensing and clinical oversight may find themselves fielding questions from residents’ families — and possibly reconsidering their pharmacy partnerships.
What Operators Should Know
The court-supervised process runs through Stretto, Omnicare’s claims agent, and is publicly accessible at OmnicareRestructuring.com. For operators with existing contracts, the bankruptcy raises questions about service continuity, contract terms, and what happens if a different buyer wins the auction in May.
GenieRx’s backing from both a private equity firm and a healthcare-focused investment group suggests the buyer sees long-term value in Omnicare’s nursing home relationships. But it’s worth noting that this kind of court process routinely invites competing bids — and the final owner come June could be someone else entirely.
The pharmacy side of long-term care has faced mounting pressure on medication management protocols in recent years, with CMS scrutiny on antipsychotic use and new clinical recommendations now reshaping how facilities approach dispensing and oversight. Whoever ends up owning Omnicare will inherit both a large book of nursing home clients and those escalating regulatory expectations.
Omnicare, a subsidiary of CVS Health, serves skilled nursing facilities and independent and assisted living communities across the country. CVS acquired the company for $12.7 billion in 2015 in one of the largest deals in long-term care pharmacy history.
Industry reports have not yet addressed the full scope of what a new owner could mean for the nursing home facilities currently under Omnicare contracts, but operators should expect more clarity once the auction plays out in May.
